Find therapies in clinical trials near you – page 260

Study on Giredestrant or Tamoxifen for Premenopausal Women with Early ER-Positive, HER2-Negative Breast Cancer

Study on Giredestrant or Tamoxifen for Premenopausal Women with Early ER-Positive, HER2-Negative Breast Cancer

Study on BIA 28-6156 for Parkinson's Disease in Patients with GBA1 Gene Variant

Study on BIA 28-6156 for Parkinson's Disease in Patients with GBA1 Gene Variant

Long-Term Follow-Up Study of Imlifidase in Highly Sensitized Kidney Transplant Patients

Long-Term Follow-Up Study of Imlifidase in Highly Sensitized Kidney Transplant Patients

Study on the Effects of Ecopipam Hydrochloride for Children and Adolescents with Tourette's Disorder

Study on the Effects of Ecopipam Hydrochloride for Children and Adolescents with Tourette's Disorder

Study on the Safety and Effectiveness of THE-630 for Patients with Advanced Gastrointestinal Stromal Tumors (GIST)

Study Comparing Risankizumab and Ustekinumab for Adults with Moderate to Severe Crohn's Disease After Anti-TNF Therapy Failure

Study on Valbenazine for Patients with Schizophrenia Not Responding Well to Antipsychotic Treatment

Study on Valbenazine for Patients with Schizophrenia Not Responding Well to Antipsychotic Treatment

Study Comparing DZD9008 and Chemotherapy for First-Line Treatment in Patients with Advanced Non-Small Cell Lung Cancer with EGFR Exon 20 Mutation

Study Comparing DZD9008 and Chemotherapy for First-Line Treatment in Patients with Advanced Non-Small Cell Lung Cancer with EGFR Exon 20 Mutation

Study on Secukinumab and Prednisone for Patients with Polymyalgia Rheumatica Who Have Recently Relapsed

Study of Relatlimab and Nivolumab for Patients with Advanced Liver Cancer Who Have Not Received Immunotherapy After Tyrosine Kinase Inhibitor Treatment

Study of Relatlimab and Nivolumab for Patients with Advanced Liver Cancer Who Have Not Received Immunotherapy After Tyrosine Kinase Inhibitor Treatment

Study on the Safety and Effectiveness of SKB264 and Pembrolizumab for Patients with Cervical, Urothelial, Ovarian, or Prostate Cancer

Study on the Safety and Effectiveness of SKB264 and Pembrolizumab for Patients with Cervical, Urothelial, Ovarian, or Prostate Cancer

Study of Pembrolizumab as Additional Treatment for Patients with Liver Cancer (Hepatocellular Carcinoma) After Surgery or Local Ablation

Study of Pembrolizumab as Additional Treatment for Patients with Liver Cancer (Hepatocellular Carcinoma) After Surgery or Local Ablation